The OvaCure Team



Scientific & Clinical Advisory Board

The members of the OvaCure Scientific and Clinical Advisory Board are carefully selected according to their international experience and recognition in the following therapeutic areas: gynaecology, oncology, immunotherapy and T-cell therapy. This equips OvaCure with the required competences to treat and cure ovarian cancer. The members of the Scientific and Clinical Advisory Board do not receive compensation, but have the opportunity to submit projects to the Project Call. 

George Coukos

Professor, MD, Director of the Department of Oncology at the University Hospitals of Canton Vaud (CHUV) and the University of Lausanne (UNIL), Director of Lausanne Branch of the Ludwig Institute for Cancer Research.

In his long career as clinician and cancer researcher, Prof. Coukos has worked especially with immunotherapy and the exploration of tumor immunology, with focus on ovarian cancer.

Carl June

Professor, MD, at the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine of the University of Pennsylvania, Director of the Center for Cellular Immunotherapy at the University of Pennsylvania, Philadelphia, PA, USA.

Prof. June is an expert in Adoptive T-cell therapy and T-cell co-stimulation. He is recognized as a pioneer in the field of immunotherapy, most widely known for the development of T-cell therapy for cancer.

Lydie Meheus

PhD, Managing Director of the Anticancer Fund, Belgium and Executive Director of Reliable Cancer Therapies, Belgium.

In her work with the Anticancer Fund, Dr. Meheus focuses on the cure of cancer patients by developing promising cancer treatments that are currently neglected and providing free comprehensive, evidence-based information about cancer treatments.

 

Mansoor Raza Mirza

MD, Chief Oncologist at the Department of Oncology, University Hospital of Copenhagen, Copenhagen, Denmark.

Dr. Mirza has extensive experience in clinical protocol development, trial conduct and regulation. He represents the Medical Director of the Nordic Society of Gynaecological Oncology (NSGO). He is Chairman of Danish Gynaecological Cancer Society and an active member of the European Network of Gynaecologic Oncology Trials Group and in the Gynaecologic Cancer Intergroup.

 

Eric Pujade-Lauraine

MD, Professor of Medical Oncology at the University Paris Descartes, Head of the Women Cancer and Clinical Research Department at the Hôpitaux Universitaires Paris Centre, site Hôtel-Dieu, AP-HP, France.

Dr. Pujade-Lauraine is the founder of the French GINECO Group, devoted to clinical research in gynaecologic cancer and co-chair of the French gynaecologic rare tumour network. Member of the American Society of Clinical Oncology, the European Society for Medical Oncology and the Gynaecologic Cancer Intergroup.

Inge Marie Svane

MD, Professor, Director of Center for Cancer Immune Therapy (CCIT), Copenhagen University Hospital Herlev, Herlev, Denmark.

Prof. Svane is an International pioneer in cancer immunotherapy, including adoptive T-cell therapy with tumour infiltrating lymphocytes and has produced encouraging results in malignant melanoma and, recently, in ovarian cancer.

 


Juliane.jpg

The late Juliane Meulengracht Bang

Co-founder of OvaCure, DK
MBA, INSEAD and Social Entrepreneur

Caroline Heering.jpg

Caroline Heering

Co-founder of OvaCure, DK
Director at Ole Kirk's Foundation

Henriette.jpg

Henriette Svarre Nielsen

Co-founder of OvaCure, DK
MD at Copenhagen University Hospital & Associate


OvaCure Board

Susanne Skovgaard Nickelsen.jpg

Susanne Skovgaard Nickelsen

Director, Clinical and Medical Affairs, Radiometer

 

ulrikke.jpg

Ulrikke Olufsen

Senior Partner & Founder at CapaHouse, DK
Cand Merc. & MBA, Copenhagen Business School.

 

alexander.jpg

Alexander Peitersen

Regional CEO for Publicis Communication in The Nordics and Chairman of OvaCure International Board of Trustees.

 

anne-cathrine.jpg

Anne Cathrine Wilhjelm

Partner and Lawyer at SEED Capital.

Pernille.jpg

Pernille Randrup Deleuran

Head of the International Department, Danish Parliament (Folketinget).


 

box.jpg

 

 


OvaCure Foundation Board (US)

Alexander Peitersen

MSc, MBA
Founder Reputation, CEO Publicis Communication Norden and Chairman of OvaCure International Board of Trustees

Crystal Hayling

MMS Stanford, Aspen Institute, Founder C2 Projects
Philantropic Leader & Changemaker

03-09-17_373.jpg

Kristin Parello-Plesner

MLA Harvard
Organisational Management & Communication

marie-louise-hom.jpg

Marie-Louise Høm

MA Organisational Psychology
Strategy Consultant


The Office

03-09-17_373.jpg

Kristin Parello-Plesner

Strategic Director
MLA Harvard Organisational Management & Communication

kristin@ovacure.org
(+45) 91 67 53 94
(+1) 202 341 8740

Josefine.jpg

Josefine Svalling

Communication Manager
MSc. Business Administration and Psychology

josefine@ovacure.org
(+45) 28 61 05 50

Screenshot 2017-11-30 11.18.33.png

Adoracion (Dori) Pegalajar-Jurado

Senior Scientific Manager
PhD. Bio-interface Engineering. MSc. Chemical Engineering

adoracion@ovacure.org
(+45) 71 48 62 66

03-09-17_347.jpg

Sara Philip Bjerg

Communication Associate
Cand.Merc. International Marketing and Management

sara@ovacure.org
(+45) 40 76 11 37

 

03-09-17_186.jpg

Carsten Lindberg Fagö-Olsen

Medical Advisor
MD, PhD

Manuela.png

Manuela Milanesi

Communication Support                          Cand. Merc. Corporate Communication

manuela@ovacure.com                                +45 28 19 23 21